Suppr超能文献

ABCC6基因敲低通过调控肝细胞癌中的PPARα促进细胞增殖。

ABCC6 Knockdown Fuels Cell Proliferation by Regulating PPARα in Hepatocellular Carcinoma.

作者信息

Zhao Zhicong, Zhao Zhenjun, Wang Jianye, Zhang He, Xi Zhifeng, Xia Qiang

机构信息

Department of Liver Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Department of Systems Biology, Beckman Research Institute of City of Hope, Duarte, CA, United States.

出版信息

Front Oncol. 2022 Feb 24;12:840287. doi: 10.3389/fonc.2022.840287. eCollection 2022.

Abstract

The ATP binding cassette (ABC) transporter family is ubiquitous in eukaryotes, specifically in vertebrates, and plays a crucial role in energy homeostasis, cell signaling, and drug resistance. Accumulating evidence indicates that some ABC transporters contribute to cancer cell proliferation and tumor progression; however, relatively little is known about the behavior of the ABC transporter family in hepatocellular carcinoma (HCC). By analyzing two public transcriptomic databases, we evaluated the effect of genes in the ABC transporter family on HCC prognostic prediction; ABCC6 was selected for further study. Notably, ABCC6 was found to be downregulated in HCC tissues and correlated with favorable outcomes in patients with HCC. Moreover, knockdown not only significantly promoted cell proliferation and , but also inhibited cell cycle arrest and cell apoptosis. Transcriptome analysis revealed that depletion enhanced the "mitotic cell cycle" and "DNA replication" pathways, and suppressed the "PPAR signaling pathway". Further investigation demonstrated that PPARα, one of the key regulators in peroxisome metabolism, is located downstream of ABCC6. In summary, our study provides profound insights into the behavior of ABC transporter family genes in various HCC cohorts, identifies ABCC6 as a biomarker for early-stage HCC diagnosis, and offers experimental basis for further investigations of targeting ABCC6 in the treatment of patients with HCC.

摘要

ATP结合盒(ABC)转运蛋白家族在真核生物中普遍存在,特别是在脊椎动物中,并且在能量稳态、细胞信号传导和耐药性方面发挥着关键作用。越来越多的证据表明,一些ABC转运蛋白有助于癌细胞增殖和肿瘤进展;然而,关于ABC转运蛋白家族在肝细胞癌(HCC)中的行为相对知之甚少。通过分析两个公共转录组数据库,我们评估了ABC转运蛋白家族中的基因对HCC预后预测的影响;选择ABCC6进行进一步研究。值得注意的是,发现ABCC6在HCC组织中下调,并且与HCC患者的良好预后相关。此外,敲低不仅显著促进细胞增殖,而且抑制细胞周期停滞和细胞凋亡。转录组分析显示,ABCC6缺失增强了“有丝分裂细胞周期”和“DNA复制”途径,并抑制了“PPAR信号通路”。进一步研究表明,过氧化物酶体代谢中的关键调节因子之一PPARα位于ABCC6的下游。总之,我们的研究为ABC转运蛋白家族基因在各种HCC队列中的行为提供了深刻见解,将ABCC6鉴定为早期HCC诊断的生物标志物,并为进一步研究靶向ABCC6治疗HCC患者提供了实验依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78f7/8907651/10ada568031f/fonc-12-840287-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验